Protofibrils of amyloid β-protein inhibit specific K+ currents in neocortical cultures

Neurobiology of Disease

Volumn 13, Issue 3, 2003, Pages 177-190

  Ye, Chian P ^a   Selkoe, Dennis J ^a   Hartley, Dean M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Partners Research Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM ION; MEMBRANE PROTEIN;

ACTION POTENTIAL; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EMBRYO; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MOLECULAR WEIGHT; NEOCORTEX; NERVE CELL NETWORK; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; SYNAPSE; VOLTAGE CLAMP;

EID: 0042405095     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-9961(03)00068-8     Document Type: Article

References (37)

1. Abele A.E., Scholz K.P., Scholz W.K., Miller R.J. Excitotoxicity induced by enhanced excitatory neurotransmission in cultured hippocampal pyramidal neurons. Neuron. 4:1990;413-419.
2. Bagetta G., Nair S., Nistico G., Dolly J.O. Hippocampal damage produced in rats by alpha-dendrotoxin - a selective K+ channel blocker - involves non-NMDA receptor activation. Neurochem. Int. 24:1994;81-90.
3. Buckle P.J., Haas H.L. Enhancement of synaptic transmission by 4-aminopyridine in hippocampal slices of the rat. J. Physiol. 326:1982;109-122.
4. Changqing X., Caiyun Q., Zongming Z., Caihong W., Paiai Z., Xiuling L. Effects of beta-amyloid peptide on transient outward potassium current of acutely dissociated hippocampal neurons in CA1 sector in rats. Chin. Med. J. 111:1998;492-495.
5. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V., Hyman B.T., Younkin S.G., Hsiao K.K. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2:1999;271-276.
6. Dodart J.C., Bales K.R., Gannon K.S., Greene S.J., DeMattos R.B., Mathis C., DeLong C.A., Wu S., Wu X., Holtzman D.M., Paul S.M. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat. Neurosci. 5:2002;452-457.
7. Etcheberrigaray R., Ito E., Kim C.S., Alkon D.L. Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels. Science. 264:1994;276-279.
8. Good T.A., Smith D.O., Murphy R.M. Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons. Biophys. J. 70:1996;296-304.
9. Gouras G.K., Tasi J., Naslund J., Vincent B., Edgar M., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H., Greengard P., Relkin N.R. Intraneuronal Aβ42 accumulation in human brain. Am. J. Pathol. 156:2000;15-20.
10. Grynkiewicz G., Poenie M., Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
11. Halliwell J.V., Othman I.B., Pelchen-Matthews A., Dolly J.O. Central action of dendrotoxin selective reduction of a transient K conductance in hippocampus and binding to localized acceptors . Proc. Natl. Acad. Sci. USA. 83:1986;493-497.
12. Harper J.D., Wong S.S., Lieber C.M., Lansbury P.T. Jr. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem. Biol. 4:1997;119-125.
13. Hartley D., Walsh D.M., Ye C.P., Diehl T., Vasquez S., Vassilev P.M., Teplow D.B., Selkoe D.J. Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19:1999;8876-8884.
14. Hille B. Ion Channels of Excitable Membranes. 3rd ed: 2001;Sinauer, Sunderland, MA.
15. Holcomb L., Gordon M.N., McGowan E., Yu X., Benkovic S., Jantzen P., Wright K., Saad I., Mueller R., Morgan D., Sanders S., Zehr C., O'Campo K., Hardy J., Prada C.M., Eckman C., Younkin S., Hsiao K., Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nature Med. 4:1998;97-100.
16. Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., Kholodenko D., Malenka R.C., Nicoll R.A., Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA. 96:1999;3228-3233.
17. Kotilinek L.A., Bacskai B., Westerman M., Kawarabayashi T., Younkin L., Hyman B.T., Younkin S., Ashe K.H. Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J. Neurosci. 22:2002;6331-6335.
18. 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA. 95:1998;6448-6453.
19. Lue L.F., Kuo Y.M., Roher A.E., Brachova L., Shen Y., Sue L., Beach T., Kurth J.H., Rydel R.E., Rogers J. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155:1999;853-862.
20. Massengill J.L., Smith M.A., Son D.I., O'Dowd D.K. Differential expression of K4-AP currents and Kv3.1 potassium channel transcripts in cortical neurons that develop distinct firing phenotypes. J. Neurosci. 17:1997;3136-3147.
21. McLean C.A., Cherny R.A., Fraser F.W., Fuller S.J., Smith M.J., Beyreuther K., Bush A.I., Masters C.L. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46:1999;860-866.
22. Meiri N., Sun M.K., Segal Z., Alkon D.L. Memory and long-term potentiation (LTP) dissociated normal spatial memory despite CA1 LTP elimination with Kv1.4 antisense . Proc. Natl. Acad. Sci. USA. 95:1998;15037-15042.
23. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice synaptotoxicity without plaque formation . J. Neurosci. 20:2000;4050-4058.
24. Nilsberth C., Westlind-Danielsson A., Eckman C.B., Condron M.M., Axelman K., Forsell C., Stenh C., Luthman J., Teplow D.B., Younkin S.G., Naslund J., Lannfelt L. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat. Neurosci. 4:2001;887-893.
25. Ramakers G.M., Storm J.F. A postsynaptic transient K(+) current modulated by arachidonic acid regulates synaptic integration and threshold for LTP induction in hippocampal pyramidal cells. Proc. Natl. Acad. Sci. USA. 99:2002;10144-10149.
26. Reinhart P.H., Chung S., Levitan I.B. A family of calcium-dependent potassium channels from rat brain. Neuron. 2:1989;1031-1041.
27. Robinson H.P., Kawahara M., Jimbo Y., Torimitsu K., Kuroda Y., Kawana A. Periodic synchronized bursting and intracellular calcium transients. J. Neurophysiol. 70:1993;1606-1616.
28. Sattler R., Tymianski M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24:2000;107-129.
29. Storm J.F. Potassium currents in hippocampal pyramidal cells. Prog. Brain Res. 83:1990;161-187.
30. Sze C.I., Troncoso J.C., Kawas C., Mouton P., Price D.L., Martin L.J. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:1997;933-944.
31. Terry R.D., Masliah E., Salmon .D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease synapse loss is the major correlate of cognitive impairment . Ann. Neurol. 30:1991;572-580.
32. Van Goor F., Krsmanovic L.Z., Catt K.J., Stojilkovic S.S. Control of action potential-driven calcium influx in GT1 neurons by the activation status of sodium and calcium channels. Mol. Endocrinol. 13:1999;587-603.
33. Walsh D., Klyubin I., Fadeeva J., William K., Cullen W., Anwyl R., Wolfe M., Rowan M., Selkoe D. Naturally secreted oligomers of the Alzheimer amyloid β-protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:2002;535-539.
34. Walsh D.M., Hartley D.M., Kusumoto Y., Fezoui Y., Condron M.M., Lomakin A., Benedek G.B., Selkoe D.J., Teplow D.B. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274:1999;25945-25952.
35. Walsh D.M., Lomakin A., Benedek G.B., Maggio J.E., Condron M.M., Teplow D.B. Amyloid β-protein fibrillogenesis Detection of a protofibrillar intermediate . J. Biol. Chem. 272:1997;22364-22374.
36. Wang H.W., Pasternak J.F., Kuo H., Ristic H., Lambert M.P., Chromy B., Viola K.L., Klein W.L., Stine W.B., Krafft G.A., Trommer B.L. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res. 924:2002;133-140.
37. 2+ oscillations in cortical neurons. Brain Res. 767:1997;239-249.